Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 18;4(Suppl 1):e000790.
doi: 10.1136/rmdopen-2018-000790. eCollection 2018.

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines

Affiliations

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines

Alberto Sulli et al. RMD Open. .

Abstract

Objective: To report the effort of the European Reference Network for Rare and Complex CONnective tissue and musculoskeletal diseases NETwork working group on Ehlers-Danlos syndromes (EDS) and related disorders to assess current available clinical practice guidelines (CPGs) specifically addressed to EDS, in order to identify potential clinician and patient unmet needs.

Methods: Systematic literature search in PUBMED and EMBASE based on controlled terms (MeSH and Emtree) and keywords of the disease and publication type (CPGs). All the published articles were revised in order to identify existing CPGs on diagnosis, monitoring and treatment of EDS.

Results: Literature revision detected the absence of papers reporting good quality CPGs to optimise EDS patient care. The current evidence-based literature regarding clinical guidelines for the EDS was limited in size and quality, and there is insufficient research exploring the clinical features and interventions, and clinical decision-making are currently based on theoretical and limited research evidences.

Conclusions: Many clinician and patient unmet needs have been identified.

Keywords: ERN ReCONNET; Ehlers-Danlos syndromes; European Reference Networks; clinical practice guidelines; unmet needs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared

Figures

Figure 1
Figure 1
Flowchart of literature revision to identify current available clinical practice guidelines (CPGs) specifically addressed to Ehlers-Danlos Syndromes (EDS) on diagnosis, monitoring and treatment, according to the Institute of Medicine 2011 definition (ref. 7).

References

    1. Malfait F. Vascular aspects of the Ehlers-Danlos syndromes. Matrix Biol 2018;71-72:380–95. 10.1016/j.matbio.2018.04.013 - DOI - PubMed
    1. Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31–7. - PubMed
    1. Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8–26. 10.1002/ajmg.c.31552 - DOI - PubMed
    1. Cutolo M, Castellani P, Borsi L, et al. Altered fibronectin distribution in cultured fibroblasts from patients with Ehlers-Danlos syndrome. Clin Exp Rheumatol 1986;4:125–8. - PubMed
    1. Castori M, Tinkle B, Levy H, et al. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet 2017;175:148–57. 10.1002/ajmg.c.31539 - DOI - PubMed

LinkOut - more resources